Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.
Ricerca Clinica Co., 812-0013 Fukuoka, Japan.
Vaccine. 2023 Oct 26;41(45):6672-6678. doi: 10.1016/j.vaccine.2023.09.051. Epub 2023 Sep 27.
The emergence of omicron variants exhibiting antigenic changes has led to an increase in breakthrough infection among individuals with a wild-type SARS-CoV-2 vaccine booster. The correlation between post-booster spike-specific antibodies and omicron infection risk remains unclear.
This prospective cohort study included SARS-CoV-2-naive healthcare workers with three-dose BNT162b2. Post-booster spike-specific IgG and interferon-γ levels were measured. Breakthrough infection was documented during a 10-month omicron-predominant period. Household and healthcare contacts were followed to identify subsequent infections. The IgG titers were additionally measured at the end of follow-up, and the titers at exposure were estimated from the two-point titers.
Of 333 participants, 89 developed infection, of whom 37 (41.6 %) were household contacts. Kaplan-Meier curves indicated that higher IgG titers were significantly correlated with lower cumulative infection incidence (p = 0.029), whereas the interferon-γ levels were not (p = 0.926). Multivariate Cox analysis showed that increasing IgG titers were associated with a reduced hazard ratio (HR) of 0.26 (95% CI, 0.12-0.55). Household exposure posed a greater infection risk than healthcare exposure (HRs, 11.24 [6.88-18.40] vs. 2.82 [1.37-5.44]). The difference in geometric mean IgG titers of infected and uninfected participants was significant among household contacts (20,244 AU/mL vs. 13,842 AU/mL, p = 0.031). Estimation of IgG titers at exposure showed a significantly higher infection incidence in those exposed with titers of <3,000 AU/mL than in those with higher titers (79.2 % vs. 32.3 %, p < 0.001).
Spike-specific antibodies induced by a wild-type SARS-CoV-2 vaccine booster are suggested to be effective in protecting against omicron infection. Household exposure would be a significant source of infection for hospital healthcare workers.
具有抗原性变化的 omicron 变体的出现导致接受野生型 SARS-CoV-2 疫苗加强针的个体突破性感染增加。加强针后刺突特异性抗体与 omicron 感染风险之间的相关性尚不清楚。
本前瞻性队列研究纳入了接受三剂 BNT162b2 的 SARS-CoV-2 初治医护人员。测量了加强针后刺突特异性 IgG 和干扰素-γ水平。在 omicron 占主导地位的 10 个月期间记录突破性感染。随访期间监测家庭和医疗接触者以识别随后的感染。在随访结束时还测量了 IgG 滴度,并根据两点滴度估计暴露时的滴度。
333 名参与者中,89 人发生感染,其中 37 人(41.6%)为家庭接触者。Kaplan-Meier 曲线表明,较高的 IgG 滴度与较低的累积感染发生率显著相关(p=0.029),而干扰素-γ水平则不然(p=0.926)。多变量 Cox 分析表明,IgG 滴度增加与降低的风险比(HR)相关,为 0.26(95%CI,0.12-0.55)。家庭暴露比医疗暴露具有更大的感染风险(HRs,11.24 [6.88-18.40] vs. 2.82 [1.37-5.44])。家庭接触者中感染和未感染参与者的几何平均 IgG 滴度差异显著(20244 AU/mL vs. 13842 AU/mL,p=0.031)。暴露时 IgG 滴度的估计表明,暴露于<3000 AU/mL 滴度的个体感染发生率显著高于暴露于更高滴度的个体(79.2% vs. 32.3%,p<0.001)。
野生型 SARS-CoV-2 疫苗加强针诱导的刺突特异性抗体被认为能有效预防 omicron 感染。家庭暴露将成为医院医护人员感染的重要来源。